Anticoagulants, primarily warfarin, are used to prevent thrombosis and thromboembolism in patients with atrial ...
EP Lab
This channel includes news and new technology innovations for cardiac electrophysiology (EP) systems, techniques and devices using in EP labs. This includes implantable EP devices, pacemakers, implantable cardioverter defibrillators (ICD), cardiac resychronization therapy (CRT), ablation technologies, left atrial appendage (LAA) occlusion, atrial fibrilation (AF) and Holter monitors.
July 12, 2012 — BioControl Medical has announced U.S. Food and Drug Administration (FDA) approval to begin the second ...
July 11, 2012 — Biotronik announced enrollment is now complete for the SPIRIT-ICD study, with 503 patients from 37 sites ...
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
July 11, 2012 — St. Jude Medical received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the ...
July 6, 2012 — Boston Scientific Corp. has completed enrollment in the PREVAIL confirmatory study, designed to gain U.S ...
June 25, 2012 — St. Jude Medical Inc. today commented on the Durata lead failure reported in the MAUDE database report ...
Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness ...
June 21, 2012 — A class action suit has been filed against St. Jude Medical Inc. on behalf of purchasers of the company ...
June 18, 2012 — Epicardial ablation device maker Contact Inc. announced that new long-term physician data demonstrated ...
June 18, 2012 — Endosense announced its TactiCath Quartz force-sensing ablation catheter has been CE mark approved for ...
Washington Health System (WHS) provides healthcare services at more than 40 offsite locations across three counties in ...
June 15, 2012 — Boston Scientific Corp. has initiated use of the Latitude NXT Remote Patient Management System with ...
June 15, 2012 —Endosense, a pioneer and leader in force-sensing technology focused on improving the efficacy and safety ...
June 15, 2012 — Cardiosolutions Inc. announced it has received 510(k) clearance from the U.S. Food and Drug ...
Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness ...
June 13, 2012 — AliveCor announced it has raised $10.5 million in Series B venture financing. The financing comes on the ...
June 8, 2012 — Boston Scientific Corp. has closed its acquisition of Cameron Health, Inc. of San Clemente, Calif., and ...
June 11, 2012 — Boehringer Ingelheim Pharmaceuticals Inc. announced that the Pradaxa (dabigatran etexilate mesylate) ...